Current and future therapeutic prokinetic therapy to improve enteral feed intolerance in the ICU patient

Nutrition in Clinical Practice

Volumn 25, Issue 1, 2010, Pages 26-31

  Fraser, Robert J L ^a   Bryant, Laura ^a  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

Critical illness; Enteral nutrition; Gastrointestinal motility

Indexed keywords

ALEMCINAL; ALVIMOPAN; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CLARITHROMYCIN; ERYTHROMYCIN; LOXIGLUMIDE; MACROLIDE; METOCLOPRAMIDE; MORPHINE; NALOXONE; PLACEBO; PROKINETIC AGENT;

CLINICAL TRIAL; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DRUG TREATMENT FAILURE; DYSPEPSIA; ENTERIC FEEDING; GASTRIC DYSMOTILITY; GASTROINTESTINAL MOTILITY DISORDER; HUMAN; INTENSIVE CARE UNIT; LOW DRUG DOSE; MALNUTRITION; MIGRATING MYOELECTRIC COMPLEX; NUTRITIONAL INTOLERANCE; PARENTERAL NUTRITION; PRIMARY PREVENTION; REVIEW; STOMACH EMPTYING;

CRITICAL ILLNESS; ENTERAL NUTRITION; ERYTHROMYCIN; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HUMANS; INTENSIVE CARE UNITS; MALNUTRITION; METOCLOPRAMIDE; PARENTERAL NUTRITION;

EID: 77952598331     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533609357570     Document Type: Review

References (46)

1. McClave SA, Sexton LK, Spain DA, et al. Enteral tube feeding in the intensive care unit: factors impeding adequate delivery. Crit Care Med. 1999;27:1252-1256.
2. De Beaux, Chapman M, Fraser R, et al. Enteral nutrition in the critically ill: a prospective survey in an Australian intensive care unit. Anaesth Intensive Care. 2001;29:619-622.
3. Jones D, George C, Hart GK, Bellomo R, Martin J. Introduction of medical emergency teams in Australia and New Zealand: a multicentre study. Crit Care. 2008;12:R46.
4. Villet S, Chiolero RL, Bollmann MD, et al. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr. 2005;24:502-509.
5. Kang W, Kudsk KA. Is there evidence that the gut contributes to mucosal immunity in humans? JPEN J Parenter Enteral Nutr. 2007;31:246-258.
6. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998;129:433-440.
7. Nguyen NQ, Fraser RJ, Bryant LK, Holloway RH. Functional association between proximal and distal gastric motility during fasting and duodenal nutrient stimulation in humans. Neurogastroenterol Motil. 2007;19:638-645.
8. Horowitz M, Dent J, Fraser R, Sun W, Hebbard G. Role and integration of mechanisms controlling gastric emptying. Dig Dis Sci. 1994;39(12 suppl):7S-13S.
9. Heddle R, Collins PJ, Dent J, et al. Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion. J Gastroenterol Hepatol. 1989;4:437-447.
10. Hausken T, Gilja OH, Odegaard S, Berstad A. Flow across the human pylorus soon after ingestion of food, studied with duplex sonography: effect of glyceryl trinitrate. Scand J Gastroenterol. 1998;33:484-490.
11. Vozzo R, Su YC, Fraser RJ, et al. Antropyloroduodenal, cholecystokinin and feeding responses to pulsatile and non-pulsatile intraduodenal lipid infusion. Neurogastroenterol Motil. 2002;14:25-33.
12. Vantrappen G, Janssens J, Hellemans J, Ghoos Y. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest. 1977;59:1158-1166.
13. Dive A, Moulart M, Jonard P, Jamart J, Mahieu P. Gastroduodenal motility in mechanically ventilated critically ill patients: a manometric study. Crit Care Med. 1994;22:441-447. (Pubitemid 24085296)
14. Dive A, Miesse C, Jamart J, Evrard P, Gonzalez M, Installe E. Duodenal motor response to continuous enteral feeding is impaired in mechanically ventilated critically ill patients. Clin Nutr. 1994;13:302-306.
15. Nguyen NQ, Fraser RJ, Chapman M, et al. Proximal gastric response to small intestinal nutrients is abnormal in mechanically ventilated critically ill patients. World J Gastroenterol. 2006;12:4383-4388.
16. Chapman M, Fraser R, Vozzo R, et al. Antro-pyloro-duodenal motor responses to gastric and duodenal nutrient in critically ill patients. Gut. 2005;54:1384-1390.
17. Nguyen NQ, Fraser RJ, Chapman MJ, et al. Feed intolerance in critical illness is associated with increased basal and nutrient-stimulated plasma cholecystokinin concentrations. Crit Care Med. 2007;35:82-88.
18. Nguyen NQ, Fraser RJ, Chapman M, et al. Fasting and nutrientstimulated plasma peptide-YY levels are elevated in critical illness and associated with feed intolerance: an observational, controlled study. Crit Care. 2006;10:R175.
19. Deane A, Chapman MJ, Fraser RJ, Bryant LK, Burgstad C, Nguyen NQ. Mechanisms underlying feed intolerance in the critically ill: implications for treatment. World J Gastroenterol. 2007;13:3909-3917.
20. MacLaren R, Kiser TH, Fish DN, Wischmeyer PE. Erythromycin vs metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition in critically ill patients. JPEN J Parenter Enteral Nutr. 2008;32:412-419.
21. Nguyen NQ, Chapman MJ, Fraser RJ, Bryant LK, Holloway RH. Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Crit Care Med. 2007;35:483-489.
22. Rhoney DH, Parker D Jr, Formea CM, Yap C, Coplin WM. Tolerability of bolus versus continuous gastric feeding in braininjured patients. Neurol Res. 2002;24:613-620.
23. Janssens J, Peeters TL, Vantrappen G, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med. 1990;322:1028-1031.
24. Sarna SK, Soergel KH, Koch TR, et al. Gastrointestinal motor effects of erythromycin in humans. Gastroenterology. 1991;101:1488-1496.
25. Fraser R, Shearer T, Fuller J, Horowitz M, Dent J. Intravenous erythromycin overcomes small intestinal feedback on antral, pyloric, and duodenal motility. Gastroenterology. 1992;103:114-119.
26. Chapman MJ, Fraser RJ, Kluger MT, Buist MD, De Nichilo DJ. Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding. Crit Care Med. 2000;28:2334-2337.
27. Ritz MA, Chapman MJ, Fraser RJ, et al. Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill. Intensive Care Med. 2005;31:949-954.
28. Berne JD, Norwood SH, McAuley CE, et al. Erythromycin reduces delayed gastric emptying in critically ill trauma patients: a randomized, controlled trial. J Trauma. 2002;53:422-425.
29. Depoortere I, Peeters TL, Vantrappen G. Effect of erythromycin and of octreotide on motilin receptor density in the rabbit. Regul Pept. 1991;32:85-94.
30. Nguyen N, Fraser R, Bryant L, et al. Plasma erythromycin concentrations predict feeding outcomes in critically ill patients with feed intolerance [abstract]. Gastroenterology. 2009;136(suppl 1):A-537.
31. Mittal RK, Frank EB, Lange RC, McCallum RW. Effects of morphine and naloxone on esophageal motility and gastric emptying in man. Dig Dis Sci. 1986;31:936-942.
32. Nguyen NQ, Chapman MJ, Fraser RJ, et al. The effects of sedation on gastric emptying and intra-gastric meal distribution in critical illness. Intensive Care Med. 2008;34:454-460.
33. Meissner W, Dohrn B, Reinhart K. Enteral naloxone reduces gastric tube reflux and frequency of pneumonia in critical care patients during opioid analgesia. Crit Care Med. 2003;31: 776-780.
34. Gonenne J, Camilleri M, Ferber I, et al. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. Clin Gastroenterol Hepatol. 2005;3:784-791.
35. Buchler MW, Seiler CM, Monson JR, et al. Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study. Aliment Pharmacol Ther. 2008;28:312-325.
36. Roberts DJ, Banh HL, Hall RI. Use of novel prokinetic agents to facilitate return of gastrointestinal motility in adult critically ill patients. Curr Opin Crit Care. 2006;12:295-302.
37. Nguyen NQ, Chapman M, Fraser RJ, Bryant LK, Burgstad C, Holloway RH. Prokinetic therapy for feed intolerance in critical illness: one drug or two? Crit Care Med. 2007;35:2561-2567.
38. Bortolotti M, Mari C, Brunelli F, Sarti P, Miglioli M. Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis. Dig Dis Sci. 1999;44:2439-2442.
39. Hawkyard CV, Koerner RJ. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks. J Antimicrob Chemother. 2007;59:347-358.
40. Katapadi K, Kostandy G, Katapadi M, Hussain KM, Schifter D. A review of erythromycin-induced malignant tachyarrhythmia-torsade de pointes. A case report. Angiology. 1997;48:821-826.
41. Talley NJ, Verlinden M, Snape W, et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2000;14:1653-1661.
42. Tougas G, Bovell KT, Collins SM, Dent J, Hunt RH. The effect of naloxone on lipid-induced pyloric motor response in humans. Gastroenterology. 1990;99:930-934.
43. Schwizer W, Borovicka J, Kunz P, et al. Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide. Gut. 1997;41:500-504.
44. Peeters TL. Central and peripheral mechanisms by which ghrelin regulates gut motility. J Physiol Pharmacol. 2003;54(suppl 4):95-103.
45. Canadian Clinical Practice Guidelines 2009. Critical Care Nutrition Web site. http://www.criticalcarenutrition.com/docs/cpg/srrev.pdf.
46. Nguyen NQ, Ng MP, Chapman M, Fraser RJ, Holloway RH. The impact of admission diagnosis on gastric emptying in critically ill patients. Crit Care. 2007;11:R16